Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine-induced bronchoconstriction in children

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 20, Issue 1, 2007, Pages 1-6

  Amirav, Israel ^a   Yacobov, Renata ^a   Luder, Anthony S ^a,b  

^a Rebecca Sieff Government Hospital   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Adenosine; Bronchodilators; Dry powder inhaler; Pediatrics

Indexed keywords

ADENOSINE PHOSPHATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FORMOTEROL; PLACEBO; SALBUTAMOL;

ADOLESCENT; AEROSOL; ARTICLE; BETA ADRENERGIC STIMULATION; BRONCHODILATATION; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERMETHOD COMPARISON; MALE; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

ADENOSINE MONOPHOSPHATE; ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INHALATION; MALE; NEBULIZERS AND VAPORIZERS; PLACEBOS; RECOVERY OF FUNCTION; SPIROMETRY; TIME FACTORS;

EID: 34047206495     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2006.0561     Document Type: Article

References (24)

1. Gina-Global Initiative for Asthma. 2005. Global Strategy for Asthma Management and Prevention. National Heart, Lung and Blood Institute, NIH Publication No. 02-3659 Issued January 1995, Management Segment (Chapter 7, pg. 93-148): Updated 2005 from the 2004 document. Bethesda.
2. Raimondi, A.C., Schottlender, J., Lombardi, D., and Molfino, N.A. 1997. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. Chest 112:24-28.
3. Chandra, A., Shim, C., Cohen, H.W., Chung, V., Maggiore, D., Mani, K., and Dhuper, S. 2005. Regular vs ad-lib albuterol for patients hospitalized with acute asthma. Chest 128:1115-1120.
4. Ringdal, N., Derom, E., Wahlin-Boll, E., and Pauwels, R. 1998. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler. Respir. Med. 92:1017-1021.
5. Henriksen, J.M., Agertoft, L., and Pedersen, S. 1992. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children. J. Allergy Clin. Immunol. 89: 1176-1182.
6. Prime, D., Grant, A.C., Slater, A.L., and Woodhouse, R.N. 1999. A critical comparison of the dose delivery characteristics of four alternative inhalation devices delivering salbutamol: pressurized metered dose inhaler, Diskhaler inhaler, and Turbuhaler inhaler. J. Aerosol Med. 12:75-84.
7. Malton, A., Sumby, B.S., and Smith, I.J. 1995. A comparison of in-vitro drug delivery from two multidose powder inhalation devices. Eur. J. Clin. Res. 7:177-193.
8. Pedersen, S., Hansen, O.R., and Fuglsang, G. 1990. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 65:308-310.
9. Kamps, W.A., Brand, P.L.P., and Roorda, R. 2004. Variation of Peak Inspiratory Flow Through Dry Powder Inhalers in Children With Stable and Unstable Asthma. Pediatr Pulmonol. 37:65-70.
10. Avital, A., Godfrey, S., and Springer, C. 2000. Exercise, methacholine, and adenosine-5-monophosphate challenges in children with asthma: relation to severity of the disease. Pediatr Pulmonol. 30:207-214.
11. Avital, A., Picard, E., Uwyyed, K., and Springer, C. 1995. Comparison of adenosine 5-monophosphate and methacholine for the differentiation of asthma from chronic airway diseases with the use of the auscultative method in very young children. J Pediatr. 127:438-440.
12. Polosa, R., and Holgate, S.T. 1997. Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Thorax 52:919-923.
13. Egbagbe, E., Pavord, I.D., Wilding, P., Thompson-Coon, J., and Tattersfield, A.E. 1997. Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline. Thorax 52:239-243.
14. Taylor, D.A., Jensen, M.W., Kanabar, V., Engelstatter, R., Steinijans, V.W., Barnes, P.J., and O'Conner, B.J. 1999. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5-monophosphate in asthmatic patients. Am. J. Respir. Grit. Care Med. 160:237-243.
15. Rutgers, S.R., Koeter, G.H., Van Der Mark, T.W., and Postma, D.S. 1999. Protective effect of oral terfenadine and not inhaled ipratropium on adenosine 5-monophosphate-induced bronchoconstriction in patients with COPD. Clin. Exp. Allergy. 29:1287-1292.
16. Agertoft, L., and Pedersen, S. 1998. Importance of training for correct Turbuhaler use in preschool children. Acta. Paediatr. 87:842-847.
17. 1995. Standardization of spirometry, 1994 update: American Thoracic Society. Am. J. Respir. Crit. Care Med. 152:1107-1136.
18. Knudson, R.J., Lebowitz, M.D., Holberg, C.J., and Burrows, B. 1983. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am. Rev. Respir. Dis. 127:725-734.
19. Stahl, E., Postma, D.S., Svensson, K., Tattersfield, A.E., Eivindson, A., Schreurs, A., and Lofdahl, C.G. 2003. Formoterol used as needed improves health-related quality of life in asthmatic patients uncontrolled with inhaled corticosteroids. Respir. Med. 97:1061-1066.
20. Boonsawat, W., Charoenratanakul, S., Pothirat, C., Sawanyawisuth, K., Seearamroongruang, T., Bengtsson, T., Brander, R., and Selroos, O. 2003. Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Respir. Med. 97:1067-1074.
21. Tal, A. 2002. Symbicort: Controlling asthma in children. Respir. Med. 96(suppl A):S23-S28.
22. Stallberg, B., Olsson, P., Jorgensen, L.A., Lindarck, N., and Ekstrom, T. 2003. Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. Int. J. Clin. Pract. 57: 656-661.
23. Scicchitano, R., Aalbers, R., Ukena, D., Manjra, A., Fouquert, L., Centanni, S., Boulet, L.P., Naya, I.P., and Hultquist, C. 2004. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr. Med. Res. Opin. 20:1403-1418.
24. O'Byrne, P.M., Bisgaard, H., Godard, P.P., Pistolesi, M., Palmquist, M., Zhu, Y., Ekstrom, T., and Bateman, E.D. 2005. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am. J. Respir. Crit. Care Med. 171:129-136.